GLP-1 receptor agonists: new kids in the block of renoprotection for people with type 2 diabetes and chronic kidney disease.

PMID 39392012 · Expert opinion on pharmacotherapy · 2024 · DOI 10.1080/14656566.2024.2416584

Authors: Theocharis Koufakis; Djordje S Popovic; Paschalis Karakasis; Panagiotis Georgianos; Dimitrios Patoulias

Abstract

No abstract published for this record.

PubMed record

Cite

Theocharis Koufakis; Djordje S Popovic; Paschalis Karakasis; Panagiotis Georgianos; Dimitrios Patoulias. GLP-1 receptor agonists: new kids in the block of renoprotection for people with type 2 diabetes and chronic kidney disease. Expert opinion on pharmacotherapy (2024). PMID 39392012. DOI 10.1080/14656566.2024.2416584.

Copy citation